Literature DB >> 11829743

Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis.

Richard J Ward1, Lucimara Chioato, Arthur H C de Oliveira, Roberto Ruller, Juliana M Sá.   

Abstract

Bothropstoxin-I (BthTx-I) is a myotoxic phospholipase A(2) variant present in the venom of Bothrops jararacussu, in which the Asp(49) residue is replaced with a lysine, which damages artificial membranes by a Ca(2+)-independent mechanism. Wild-type BthTx-I and the mutants Lys(49)-->Asp, His(48)-->Gln and Lys(122)-->Ala were expressed in Escherichia coli BL21(DE3) cells, and the hydrolytic, myotoxic and membrane-damaging activities of the recombinant proteins were compared with native BthTx-I purified from whole venom. The Ca(2+)-independent membrane-damaging and myotoxic activities of the native and wild-type recombinant BthTx-I, His(48)Gln and Lys(49)Asp mutants were similar; however, the Lys(122)Ala mutant demonstrated reduced levels of both activities. Although a low hydrolytic activity against a mixed phospholipid substrate was observed with native BthTx-I, no substrate hydrolysis was detected with the wild-type recombinant enzyme or any of the mutants. In the case of the Lys(49)Asp mutant, this demonstrates that the absence of catalytic activity in Lys(49)-PLA(2) is not a consequence of the single Asp(49)-->Lys replacement. Furthermore, these results provide unambiguous evidence that the Ca(2+)-independent membrane-damaging and myotoxic activities are maintained in the absence of hydrolysis. The evidence favours a model for a hydrolysis-independent, membrane-damaging mechanism involving an interaction of the C-terminal region of BthTx-I with the target membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829743      PMCID: PMC1222363          DOI: 10.1042/0264-6021:3620089

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  57 in total

1.  Lys-49-phospholipases A2 as active enzyme for beta-arachidonoyl phospholipid bilayer membranes.

Authors:  Y Yamaguchi; Y Shimohigashi; T Chiwata; A Tani; T Chijiwa; B Lomonte; M Ohno
Journal:  Biochem Mol Biol Int       Date:  1997-09

Review 2.  Structure and catalytic mechanism of secretory phospholipases A2.

Authors:  D L Scott; P B Sigler
Journal:  Adv Protein Chem       Date:  1994

3.  Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines in Naja nigricollis and Naja naja atra snake venom phospholipases A2.

Authors:  E Condrea; J E Fletcher; B E Rapuano; C C Yang; P Rosenberg
Journal:  Toxicon       Date:  1981       Impact factor: 3.033

4.  Catalytic role of the active site histidine of porcine pancreatic phospholipase A2 probed by the variants H48Q, H48N and H48K.

Authors:  M J Janssen; W A van de Wiel; S H Beiboer; M D van Kampen; H M Verheij; A J Slotboom; M R Egmond
Journal:  Protein Eng       Date:  1999-06

5.  A pH-induced dissociation of the dimeric form of a lysine 49-phospholipase A2 abolishes Ca2+-independent membrane damaging activity.

Authors:  A H de Oliveira; J R Giglio; S H Andrião-Escarso; A S Ito; R J Ward
Journal:  Biochemistry       Date:  2001-06-12       Impact factor: 3.162

6.  Calcium ion independent membrane leakage induced by phospholipase-like myotoxins.

Authors:  S Rufini; P Cesaroni; A Desideri; R Farias; F Gubensek; J M Gutiérrez; P Luly; R Massoud; R Morero; J Z Pedersen
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

7.  The effect of myotoxins isolated from Bothrops snake venoms on multilamellar liposomes: relationship to phospholipase A2, anticoagulant and myotoxic activities.

Authors:  C Díaz; J M Gutiérrez; B Lomonte; J A Gené
Journal:  Biochim Biophys Acta       Date:  1991-12-09

8.  Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism.

Authors:  H M Verheij; J J Volwerk; E H Jansen; W C Puyk; B W Dijkstra; J Drenth; G H de Haas
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

9.  Crystallographic and biochemical studies of the (inactive) Lys-49 phospholipase A2 from the venom of Agkistridon piscivorus piscivorus.

Authors:  D L Scott; A Achari; J C Vidal; P B Sigler
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

10.  Phospholipase-like myotoxins induce rapid membrane leakage of non-hydrolyzable ether-lipid liposomes.

Authors:  J Z Pedersen; B F de Arcuri; R D Morero; S Rufini
Journal:  Biochim Biophys Acta       Date:  1994-02-23
View more
  23 in total

1.  Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.

Authors:  Xingding Zhou; Tien-Chye Tan; S Valiyaveettil; Mei Lin Go; R Manjunatha Kini; Adrian Velazquez-Campoy; J Sivaraman
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

2.  Conodipine-P1-3, the First Phospholipases A2 Characterized from Injected Cone Snail Venom.

Authors:  Carolina Möller; W Clay Davis; Evan Clark; Anthony DeCaprio; Frank Marí
Journal:  Mol Cell Proteomics       Date:  2019-02-14       Impact factor: 5.911

3.  Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity.

Authors:  Morgane Rouault; Lachlan D Rash; Pierre Escoubas; Eric Boilard; James Bollinger; Bruno Lomonte; Thomas Maurin; Carole Guillaume; Stéphane Canaan; Christiane Deregnaucourt; Joseph Schrével; Alain Doglio; José María Gutiérrez; Michel Lazdunski; Michael H Gelb; Gérard Lambeau
Journal:  Biochemistry       Date:  2006-05-09       Impact factor: 3.162

4.  Crystallization and preliminary X-ray diffraction analysis of a Lys49-phospholipase A2 complexed with caffeic acid, a molecule with inhibitory properties against snake venoms.

Authors:  Patrícia S Shimabuku; Carlos A H Fernandes; Angelo J Magro; Tássia R Costa; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-01-22

5.  Crystallization and preliminary X-ray crystallographic studies of a Lys49-phospholipase A2 homologue from Bothrops pirajai venom complexed with rosmarinic acid.

Authors:  Juliana I dos Santos; Norival A Santos-Filho; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-05-27

6.  Topology of the substrate-binding site of a Lys49-phospholipase A2 influences Ca2+-independent membrane-damaging activity.

Authors:  Juliana Martha Sá; Lucimara Chioato; Tatiana Lopes Ferreira; Arthur H C De Oliveira; Roberto Ruller; José César Rosa; Lewis J Greene; Richard J Ward
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

7.  Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2.

Authors:  Lucimara Chioato; Arthur H C De Oliveira; Roberto Ruller; Juliana M Sá; Richard J Ward
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

8.  Crystallization and preliminary X-ray diffraction analysis of three myotoxic phospholipases A2 from Bothrops brazili venom.

Authors:  Carlos A H Fernandes; Elaine C G Gartuzo; Ivan Pagotto; Edson J Comparetti; Salomón Huancahuire-Vega; Luis Alberto Ponce-Soto; Tássia R Costa; Sergio Marangoni; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

9.  Crystallization and preliminary X-ray diffraction analysis of a novel Arg49 phospholipase A2 homologue from Zhaoermia mangshanensis venom.

Authors:  Mário T Murakami; Ulrich Kuch; Dietrich Mebs; Raghuvir K Arni
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-06-22

10.  Structural and phylogenetic studies with MjTX-I reveal a multi-oligomeric toxin--a novel feature in Lys49-PLA2s protein class.

Authors:  Guilherme H M Salvador; Carlos A H Fernandes; Angelo J Magro; Daniela P Marchi-Salvador; Walter L G Cavalcante; Roberto M Fernandez; Márcia Gallacci; Andreimar M Soares; Cristiano L P Oliveira; Marcos R M Fontes
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.